Richards T C
Cancer Res. 1977 Jun;37(6):1680-5.
The effects of the carcinogen, 1,2-dimethylhydrazine (DMH), on the proliferative characteristics of the crypt cell population of mouse colon were studied. DMH (20 mg/kg body weight) was injected s.c., weekly, for 2, 8, 16, 20, or 26 weeks. At the end of each treatment period, a group of animals was injected with [3H]thymidine and killed. After 2 weeks of DMH treatment, the crypts appeared normal histologically, but the total number of cells, the number of labeled cells, and the percentage of labeled cells per crypt column had increased. The relative distribution of labeled cells in crypt columns was not changed. DMH treatment did not affect the phases of the cell cycle of epithelial cells and the transit time of these cells through the crypt. None of the indices of crypt dynamics were altered further with the appearance of focal atypias (after 16 weeks of DMH). However, the total number of cells per crypt increased and the percentage of labeled cells decreased as adenocarcinomas developed in adjacent areas of the mucosa (after 20 to 26 weeks of DMH). The exact role of these early mucosal changes in the eventual development of malignant tumor has not been established. However, it appears that DMH carcinogenesis may involve two steps; (a) an initial increase in the number of mitotocally active cells leading to an enlarged cell population; and (b) an eventual transformation of at least some of the crypt cells of the enlarged population.
研究了致癌物1,2 - 二甲基肼(DMH)对小鼠结肠隐窝细胞群体增殖特性的影响。每周皮下注射DMH(20毫克/千克体重),持续2、8、16、20或26周。在每个治疗期结束时,给一组动物注射[3H]胸腺嘧啶核苷然后处死。DMH治疗2周后,隐窝在组织学上看起来正常,但细胞总数、标记细胞数以及每个隐窝柱中标记细胞的百分比均增加。标记细胞在隐窝柱中的相对分布没有改变。DMH治疗不影响上皮细胞的细胞周期阶段以及这些细胞通过隐窝的转运时间。随着局灶性异型增生的出现(DMH治疗16周后),隐窝动力学的各项指标均未进一步改变。然而,随着黏膜相邻区域腺癌的发展(DMH治疗20至26周后),每个隐窝的细胞总数增加而标记细胞的百分比下降。这些早期黏膜变化在恶性肿瘤最终发展过程中的确切作用尚未确定。然而,似乎DMH致癌作用可能涉及两个步骤:(a)有丝分裂活跃细胞数量最初增加导致细胞群体扩大;(b)扩大群体中至少一些隐窝细胞最终发生转化。